This coating makes things nearly indestructible.
Read more
Electronic computers are extremely powerful at performing a high number of operations at very high speeds, sequentially. However, they struggle with combinatorial tasks that can be solved faster if many operations are performed in parallel.
The EU Horizon 2020 has launched Bio4Comp, a five-year €6.1M project to build more powerful and safer biocomputers that could outperform quantum computing.
The Bio4Comp project has the ambitious goal of building a computer with greater processing speed and lower energy consumption than any of the most advanced computers existing today. Ultimately, this could translate into enabling large, error-free security software to be fast enough for practical use, potentially wiping out all current security concerns.
A total of €6.1M have been awarded to an European team of researchers from TU Dresden, Fraunhofer-Gesellschaft, Lund University, Linnaeus University and Bar Ilan University, as well as the British company Molecular Sense.
People who received regular lifestyle counseling online were able to lower their blood pressure as much as a medication would, researchers said Saturday.
Their study involved 264 people with high blood pressure and an average age of 58.
The subjects’ average blood pressure began at around 140/90 mmHg, meaning they had what is clinically known as stage 1 hypertension.
Read more
A team of researchers from Sweden, France, Belgium and Switzerland has found a way to reverse resistance to an antibiotic drug used to treat tuberculosis. In their paper published in the journal Science, the team describes how they screened compounds that activated different pathways to activate ethionaide, a compound used to treat tuberculosis.
The researchers are currently working with GlaxoSmithKline and Biotech Bioversys to further develop the small prototype molecule into a drug that can be mass produced and sold.
(Medical Xpress)—A team of researchers from Sweden, France, Belgium and Switzerland has found a way to reverse resistance to an antibiotic drug used to treat tuberculosis. In their paper published in the journal Science, the team describes how they screened compounds that activated different pathways to activate ethionaide, a compound used to treat tuberculosis.
The development of antibiotics to treat bacterial infections has very clearly made the world a healthier place. Unfortunately, over time, bacteria have been evolving to thwart such compounds, putting us all at risk once again. Because of that, scientists have been searching for new treatments, or in some cases, ways to make old treatments work again using new techniques. In this new effort, the researchers have found a way to make ethionaide, a prodrug (a compound that is metabolized in the body to produce a desired drug), become effective again in patients infected with resistant strains of Mycobacterium tuberculosis.
“A problem that I see with the current literature on open innovation is that while focusing predominantly on theoretical aspects of the concept (value proposition, strategic alignments, governance and management, human capital and culture), it pays little attention to the description of specific open innovation practices.”
So, what does everyone think so far?
Whatever else might be true of the live-action Ghost in the Shell movie, it’s also true that the filmmakers have put as much of the budget on the screen as humanly possible. And as you can tell when you watch the film’s opening scene—available here and now for your viewing pleasure—it has paid off, at least in in the visuals department.
Read more
President Donald Trump has signed a bill authorizing $19.5 billion in funding for NASA, which includes an increased focus on deep space exploration and a new goal of a manned mission to Mars.
The NASA Transition Authorization Act of 2017, or S. 442, provides funding for fiscal year 2018, which begins October 1. It specifically appropriates money for NASA’s deep space exploration, including the Space Launch System and the Orion spacecraft, as well as for the ongoing medical monitoring and treatment of astronauts. It builds on the current public-private partnership for space, with commercial companies transporting American astronauts to the International Space Station (ISS) and NASA focusing on deep space and the mission to Mars.
Read more